Araştırma Makalesi
PDF EndNote BibTex RIS Kaynak Göster

Yıl 2021, Cilt 4, Sayı 3, 289 - 294, 21.05.2021
https://doi.org/10.32322/jhsm.885485

Öz

Kaynakça

  • What is complementary and alternative medicine. National Center for Complementary and Alternative Medicine (NCCAM). http://nccam.nih.gov/health/whatiscam/. Published 2014. Accessed October 10, 2015.
  • McCarty RL, Weber WJ, Loots B, et al. Complementary and alternative medicine use and quality of life in pediatric diabetes. J Altern Complement Med 2010; 16: 165-73.
  • Muslu GK, Öztürk C. Tamamlayıcı ve alternatif tedaviler ve çocuklarda kullanımı. Çocuk Sağlığı ve Hast Derg 2008; 51: 62-7.
  • Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 1998; 280: 1569-75.
  • Kemper KJ, Vohra S, Walls R. The use of complementary and alternative medicine in pediatrics. Pediatrics 2008; 122: 1374-86.
  • Rafferty AP, McGee HB, Miller CE, Reyes M. Prevalence of complementary and alternative medicine use: State-specific estimates from the 2001 behavioral risk factor surveillance system. Am J Public Health 2002; 92: 1598-600.
  • Vallerand A, Fouladbakhsh J, Templin T. The use of complementary/alternative medicine therapies for the self-treatment of pain among residents of urban, suburban, and rural communities. Am J Public Heal 2003; 93: 923-5.
  • Molassiotis A, Fernadez-Ortega P, Pud D, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005; 16: 655-63.
  • Naja F, Alameddine M, Abboud M, Bustami D, Al Halaby R. Complementary and alternative medicine use among pediatric patients with leukemia: The case of Lebanon. Integr Cancer Ther 2011; 10: 38-46.
  • Bordbar M, Kamfiroozi R, Fakhimi N, Jaafari Z, Zarei T HS. Complementary and alternative medicine in pediatric oncology patients in South of Iran. Iran J Ped Hematol Oncol 2016; 6: 216-27.
  • Tomlinson D, Hesser T, Ethier MC, Sung L. Complementary and alternative medicine use in pediatric cancer reported during palliative phase of disease. Support Care Cancer 2011; 19:
  • Valji R, Adams D, Dagenais S, et al. Complementary and alternative medicine: a survey of its use in pediatric oncology. Evid Based Complement Alternat Med. 2013; 2013: 527163.
  • Gottschling S, Meyer S, Längler A, Scharifi G, Ebinger F, Gronwald B. Differences in use of complementary and alternative medicine between children and adolescents with cancer in Germany: a population based survey. Pediatr Blood Cancer 2014; 61: 488-92.
  • Karadeniz C, Pınarlı F, Oğuz A, Gürsel T, Canter B. Complemantery/alternative medicine use in a pediatric oncology unit in Turkey. Pediatr Blood Cancer 2007; 48: 540-3.
  • Gözüm S, Arıkan B, Büyükavcı M. Complemantery/alternative medicine use in a pediatric oncology patients in eastern Turkey. Cancer Nurs 2007; 21: 282-8.
  • Genc RE, Senol S, Turgay AS, Kantar M. Complementary and alternative medicine used by pediatric patients with cancer in Western Turkey. Oncol Nurs Forum 2009; 36: E159-64.
  • Karali Y, Demirkaya M, Sevinir B. Use of complementary and alternative medicine in children with cancer: Effect on survival. Pediatr Hematol Oncol 2012; 29: 335-44.
  • Koç Z, Tural E GE. Determining complementary and alternative medicine methods used by paediatric haematology–oncology patients. J Nurs Heal Care Chronic Illn 2011; 3: 361–71.
  • Al-Qudimat MR, Rozmus CL, Farhan N. Family strategies for managing childhood cancer: using complementary and alternative medicine in Jordan. J Adv Nurs 2011; 67: 591-7.
  • Hamidah A, Rustam ZA, Tamil AM, Zarina LA, Zulkifli ZS, Jamal R. Prevalence and parental perceptions of complementary and alternative medicine use by children with cancer in a multi-ethnic southeast Asian population. Pediatr Blood Cancer 2009; 52: 70-4.
  • Gomez-Martinez R, Tlacuilo-Parra A, Garibaldi-Covarrubias R. Use of complementary and alternative medicine in children with cancer in Occidental, Mexico. Pediatr Blood Cancer 2006; 49: 820-3.
  • Molassiotis A, Cubbin D. Thinking outside the box: complementary and alternative therapies use in paediatric oncology patients. Eur J Oncol Nurs 2004; 8: 50-60.
  • Laengler A, Spix C, Seifert G, Gottschling S, Graf N, Kaatsch P. Complementary and alternative treatment methods in children with cancer: A population-based retrospective survey on the prevalence of use in Germany. Eur J Cancer 2008; 44: 2233-40.
  • Özkan A. Çocukluk çağı kanserlerinde tat. Klin Gelişim 2013; 26: 24-32.
  • Kav S, Hanoğlu Z, Algıer L. Türkiye’de kanserli hastalarda tamamlayıcı ve alternatif tedavi yöntemlerinin kullanımı: Literatür taraması. Uluslararası Hematol Derg 2008; 18: 32-7.
  • Yeter G. Çocuk kanser hastalarında semptomlara yönelik tamamlayıcı ve alternatif tedavi kullanımı, yüksek lisans tezi. 2012.
  • Martel D, Bussieres J, Theoret Y, et al. Use of alternative and complementary therapies in children with cancer. Pediatr Blood Cancer 2005; 44: 660-8.
  • Yeh CH, Tsai JL, Li W, et al. Alternative therapy in pediatric patients in Taiwan. J Pediatr Hematol 2000; 17: 55-65.
  • June B, Anne L. Unconventional therapy use among children with cancer in Saskatchewan. J Pediatr Oncol Nurs 2001; 18: 16-25.
  • Grootenhuis MA, Last BF, de Graaf-Nijkerk JH, van der Wel M. Use of alternative treatment in pediatric oncology. Cancer Nurs 1998; 21: 282-8.

Frequency of use and characteristics of complementary and alternative treatment methods by children oncology patients

Yıl 2021, Cilt 4, Sayı 3, 289 - 294, 21.05.2021
https://doi.org/10.32322/jhsm.885485

Öz

Background/aim: The use of Complementary and Alternative Medicine (CAM) has been increasing in recent years. The aim of this study was to investigate the use of CAM and the sociodemographic characteristics of pediatric patients. Materials and methods: This cross - sectional study was completed with 139 patients newly diagnosed with or followed-up with cancer diagnosis in the pediatric oncology outpatient clinic of Ankara University Faculty of Medicine. Results: All of the patients stated that they prayed for the recovery of the disease. It was found that 26.6% of the patients used at least one CAM method. The most commonly used CAM methods were honey (59.5%), bee pollen/royal jelly (56.8%) and grape molasses (45.9%), 37.8% of the patients consulted to a muslim preacher for prayer assistance. 62% of the patients using CAM stated that they did not inform their doctor on this issue. Conclusion: Patients should be informed and warned that CAM methods should never prevent the medical treatment and should not be used instead of medical treatment, that they should share it with their doctors when they want to use any method.

Kaynakça

  • What is complementary and alternative medicine. National Center for Complementary and Alternative Medicine (NCCAM). http://nccam.nih.gov/health/whatiscam/. Published 2014. Accessed October 10, 2015.
  • McCarty RL, Weber WJ, Loots B, et al. Complementary and alternative medicine use and quality of life in pediatric diabetes. J Altern Complement Med 2010; 16: 165-73.
  • Muslu GK, Öztürk C. Tamamlayıcı ve alternatif tedaviler ve çocuklarda kullanımı. Çocuk Sağlığı ve Hast Derg 2008; 51: 62-7.
  • Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 1998; 280: 1569-75.
  • Kemper KJ, Vohra S, Walls R. The use of complementary and alternative medicine in pediatrics. Pediatrics 2008; 122: 1374-86.
  • Rafferty AP, McGee HB, Miller CE, Reyes M. Prevalence of complementary and alternative medicine use: State-specific estimates from the 2001 behavioral risk factor surveillance system. Am J Public Health 2002; 92: 1598-600.
  • Vallerand A, Fouladbakhsh J, Templin T. The use of complementary/alternative medicine therapies for the self-treatment of pain among residents of urban, suburban, and rural communities. Am J Public Heal 2003; 93: 923-5.
  • Molassiotis A, Fernadez-Ortega P, Pud D, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005; 16: 655-63.
  • Naja F, Alameddine M, Abboud M, Bustami D, Al Halaby R. Complementary and alternative medicine use among pediatric patients with leukemia: The case of Lebanon. Integr Cancer Ther 2011; 10: 38-46.
  • Bordbar M, Kamfiroozi R, Fakhimi N, Jaafari Z, Zarei T HS. Complementary and alternative medicine in pediatric oncology patients in South of Iran. Iran J Ped Hematol Oncol 2016; 6: 216-27.
  • Tomlinson D, Hesser T, Ethier MC, Sung L. Complementary and alternative medicine use in pediatric cancer reported during palliative phase of disease. Support Care Cancer 2011; 19:
  • Valji R, Adams D, Dagenais S, et al. Complementary and alternative medicine: a survey of its use in pediatric oncology. Evid Based Complement Alternat Med. 2013; 2013: 527163.
  • Gottschling S, Meyer S, Längler A, Scharifi G, Ebinger F, Gronwald B. Differences in use of complementary and alternative medicine between children and adolescents with cancer in Germany: a population based survey. Pediatr Blood Cancer 2014; 61: 488-92.
  • Karadeniz C, Pınarlı F, Oğuz A, Gürsel T, Canter B. Complemantery/alternative medicine use in a pediatric oncology unit in Turkey. Pediatr Blood Cancer 2007; 48: 540-3.
  • Gözüm S, Arıkan B, Büyükavcı M. Complemantery/alternative medicine use in a pediatric oncology patients in eastern Turkey. Cancer Nurs 2007; 21: 282-8.
  • Genc RE, Senol S, Turgay AS, Kantar M. Complementary and alternative medicine used by pediatric patients with cancer in Western Turkey. Oncol Nurs Forum 2009; 36: E159-64.
  • Karali Y, Demirkaya M, Sevinir B. Use of complementary and alternative medicine in children with cancer: Effect on survival. Pediatr Hematol Oncol 2012; 29: 335-44.
  • Koç Z, Tural E GE. Determining complementary and alternative medicine methods used by paediatric haematology–oncology patients. J Nurs Heal Care Chronic Illn 2011; 3: 361–71.
  • Al-Qudimat MR, Rozmus CL, Farhan N. Family strategies for managing childhood cancer: using complementary and alternative medicine in Jordan. J Adv Nurs 2011; 67: 591-7.
  • Hamidah A, Rustam ZA, Tamil AM, Zarina LA, Zulkifli ZS, Jamal R. Prevalence and parental perceptions of complementary and alternative medicine use by children with cancer in a multi-ethnic southeast Asian population. Pediatr Blood Cancer 2009; 52: 70-4.
  • Gomez-Martinez R, Tlacuilo-Parra A, Garibaldi-Covarrubias R. Use of complementary and alternative medicine in children with cancer in Occidental, Mexico. Pediatr Blood Cancer 2006; 49: 820-3.
  • Molassiotis A, Cubbin D. Thinking outside the box: complementary and alternative therapies use in paediatric oncology patients. Eur J Oncol Nurs 2004; 8: 50-60.
  • Laengler A, Spix C, Seifert G, Gottschling S, Graf N, Kaatsch P. Complementary and alternative treatment methods in children with cancer: A population-based retrospective survey on the prevalence of use in Germany. Eur J Cancer 2008; 44: 2233-40.
  • Özkan A. Çocukluk çağı kanserlerinde tat. Klin Gelişim 2013; 26: 24-32.
  • Kav S, Hanoğlu Z, Algıer L. Türkiye’de kanserli hastalarda tamamlayıcı ve alternatif tedavi yöntemlerinin kullanımı: Literatür taraması. Uluslararası Hematol Derg 2008; 18: 32-7.
  • Yeter G. Çocuk kanser hastalarında semptomlara yönelik tamamlayıcı ve alternatif tedavi kullanımı, yüksek lisans tezi. 2012.
  • Martel D, Bussieres J, Theoret Y, et al. Use of alternative and complementary therapies in children with cancer. Pediatr Blood Cancer 2005; 44: 660-8.
  • Yeh CH, Tsai JL, Li W, et al. Alternative therapy in pediatric patients in Taiwan. J Pediatr Hematol 2000; 17: 55-65.
  • June B, Anne L. Unconventional therapy use among children with cancer in Saskatchewan. J Pediatr Oncol Nurs 2001; 18: 16-25.
  • Grootenhuis MA, Last BF, de Graaf-Nijkerk JH, van der Wel M. Use of alternative treatment in pediatric oncology. Cancer Nurs 1998; 21: 282-8.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Bilimleri ve Hizmetleri
Bölüm Orijinal Makale
Yazarlar

İsmail BULUT>
ANKARA EĞİTİM VE ARAŞTIRMA HASTANESİ
0000-0002-7084-8002
Türkiye


Nurdan TAÇYILDIZ>
ANKARA UNIVERSITY, ANKARA FACULTY OF MEDICINE
0000-0001-5847-4733
Türkiye


Emel ÜNAL>
ANKARA UNIVERSITY, ANKARA FACULTY OF MEDICINE
0000-0001-5847-4733
Türkiye


Leman YAVUZ>
UFUK UNIVERSITY
0000-0001-8874-6621
Türkiye


Handan DİNÇASLAN>
ANKARA UNIVERSITY, FACULTY OF MEDICINE
0000-0002-1015-6784
Türkiye


Yunus Emre BULUT> (Sorumlu Yazar)
ANKARA İL SAĞLIK MÜDÜRLÜĞÜ
0000-0003-1501-2525
Türkiye

Yayımlanma Tarihi 21 Mayıs 2021
Yayınlandığı Sayı Yıl 2021, Cilt 4, Sayı 3

Kaynak Göster

Bibtex @araştırma makalesi { jhsm885485, journal = {Journal of Health Sciences and Medicine}, eissn = {2636-8579}, address = {Kırıkkale Üniversitesi Tıp Fakültesi / İç Hastalıkları Anabilim Dalı}, publisher = {MediHealth Academy Yayıncılık}, year = {2021}, volume = {4}, number = {3}, pages = {289 - 294}, doi = {10.32322/jhsm.885485}, title = {Frequency of use and characteristics of complementary and alternative treatment methods by children oncology patients}, key = {cite}, author = {Bulut, İsmail and Taçyıldız, Nurdan and Ünal, Emel and Yavuz, Leman and Dinçaslan, Handan and Bulut, Yunus Emre} }
APA Bulut, İ. , Taçyıldız, N. , Ünal, E. , Yavuz, L. , Dinçaslan, H. & Bulut, Y. E. (2021). Frequency of use and characteristics of complementary and alternative treatment methods by children oncology patients . Journal of Health Sciences and Medicine , 4 (3) , 289-294 . DOI: 10.32322/jhsm.885485
MLA Bulut, İ. , Taçyıldız, N. , Ünal, E. , Yavuz, L. , Dinçaslan, H. , Bulut, Y. E. "Frequency of use and characteristics of complementary and alternative treatment methods by children oncology patients" . Journal of Health Sciences and Medicine 4 (2021 ): 289-294 <https://dergipark.org.tr/tr/pub/jhsm/issue/62390/885485>
Chicago Bulut, İ. , Taçyıldız, N. , Ünal, E. , Yavuz, L. , Dinçaslan, H. , Bulut, Y. E. "Frequency of use and characteristics of complementary and alternative treatment methods by children oncology patients". Journal of Health Sciences and Medicine 4 (2021 ): 289-294
RIS TY - JOUR T1 - Frequency of use and characteristics of complementary and alternative treatment methods by children oncology patients AU - İsmailBulut, NurdanTaçyıldız, EmelÜnal, LemanYavuz, HandanDinçaslan, Yunus EmreBulut Y1 - 2021 PY - 2021 N1 - doi: 10.32322/jhsm.885485 DO - 10.32322/jhsm.885485 T2 - Journal of Health Sciences and Medicine JF - Journal JO - JOR SP - 289 EP - 294 VL - 4 IS - 3 SN - -2636-8579 M3 - doi: 10.32322/jhsm.885485 UR - https://doi.org/10.32322/jhsm.885485 Y2 - 2021 ER -
EndNote %0 Journal of Health Sciences and Medicine Frequency of use and characteristics of complementary and alternative treatment methods by children oncology patients %A İsmail Bulut , Nurdan Taçyıldız , Emel Ünal , Leman Yavuz , Handan Dinçaslan , Yunus Emre Bulut %T Frequency of use and characteristics of complementary and alternative treatment methods by children oncology patients %D 2021 %J Journal of Health Sciences and Medicine %P -2636-8579 %V 4 %N 3 %R doi: 10.32322/jhsm.885485 %U 10.32322/jhsm.885485
ISNAD Bulut, İsmail , Taçyıldız, Nurdan , Ünal, Emel , Yavuz, Leman , Dinçaslan, Handan , Bulut, Yunus Emre . "Frequency of use and characteristics of complementary and alternative treatment methods by children oncology patients". Journal of Health Sciences and Medicine 4 / 3 (Mayıs 2021): 289-294 . https://doi.org/10.32322/jhsm.885485
AMA Bulut İ. , Taçyıldız N. , Ünal E. , Yavuz L. , Dinçaslan H. , Bulut Y. E. Frequency of use and characteristics of complementary and alternative treatment methods by children oncology patients. J Health Sci Med / JHSM. 2021; 4(3): 289-294.
Vancouver Bulut İ. , Taçyıldız N. , Ünal E. , Yavuz L. , Dinçaslan H. , Bulut Y. E. Frequency of use and characteristics of complementary and alternative treatment methods by children oncology patients. Journal of Health Sciences and Medicine. 2021; 4(3): 289-294.
IEEE İ. Bulut , N. Taçyıldız , E. Ünal , L. Yavuz , H. Dinçaslan ve Y. E. Bulut , "Frequency of use and characteristics of complementary and alternative treatment methods by children oncology patients", Journal of Health Sciences and Medicine, c. 4, sayı. 3, ss. 289-294, May. 2021, doi:10.32322/jhsm.885485

Interuniversity Board (UAK) Equivalency: Ulakbim TR Dizin and 1b [Original research article published in journals scanned by international field indexes (included in indices other than the ones mentioned in 1a) - 10 POINTS]. The Directories (indexes) and Platforms we are included in are at the bottom of the page.

Note: Our journal is not WOS indexed and therefore is not classified as Q.

You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show







The indexes of the journal are;

       images?q=tbn:ANd9GcRB9r6zRLDl0Pz7om2DQkiTQXqDtuq64Eb1Qg&usqp=CAU

500px-WorldCat_logo.svg.png

atifdizini.png

logo_world_of_journals_no_margin.png

images?q=tbn%3AANd9GcTNpvUjQ4Ffc6uQBqMQrqYMR53c7bRqD9rohCINkko0Y1a_hPSn&usqp=CAU

doaj.png  

images?q=tbn:ANd9GcSpOQFsFv3RdX0lIQJC3SwkFIA-CceHin_ujli_JrqBy3A32A_Tx_oMoIZn96EcrpLwTQg&usqp=CAU

ici2.png

asos-index.png

drji.png





The platforms of the journal are;

COPE-logo-300x199.jpgimages?q=tbn:ANd9GcQR6_qdgvxMP9owgnYzJ1M6CS_XzR_d7orTjA&usqp=CAU

icmje_1_orig.png

cc.logo.large.png

ncbi.pngimages?q=tbn:ANd9GcRBcJw8ia8S9TI4Fun5vj3HPzEcEKIvF_jtnw&usqp=CAU

ORCID_logo.png

1*mvsP194Golg0Dmo2rjJ-oQ.jpeg


Our Journal using the DergiPark system indexed are;

Ulakbim TR Dizin,  Index Copernicus, ICI World of JournalsDirectory of Research Journals Indexing (DRJI), General Impact FactorASOS Index, OpenAIRE, MIAR,  EuroPub, WorldCat (OCLC)DOAJ,  Türkiye Citation Index, Türk Medline Index, InfoBase Index


Our Journal using the DergiPark system platforms are;

Google, Google Scholar, CrossRef (DOI), ResearchBib, ICJME, COPE, NCBI, ORCID, Creative Commons, Open Access, and etc.


Journal articles are evaluated as "Double-Blind Peer Review". 

Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user.  https//dergipark.org.tr/tr/pub/jhsm/page/9535

Journal charge policy   https://dergipark.org.tr/tr/pub/jhsm/page/10912


Editor List for 2022

Assoc. Prof. Alpaslan TANOĞLU (MD)  

Prof. Aydın ÇİFCİ (MD)

Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)

Prof. Murat KEKİLLİ (MD)

Prof. Yavuz BEYAZIT (MD) 

Prof. Ekrem ÜNAL (MD)

Prof. Ahmet EKEN (MD)

Assoc. Prof. Ercan YUVANÇ (MD)

Assoc. Prof. Bekir UÇAN (MD) 

Assoc. Prof. Mehmet Sinan DAL (MD)


Our journal has been indexed in DOAJ as of May 18, 2020.

Our journal has been indexed in TR-Dizin as of March 12, 2021.


17873

Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.